05, August, 2025

Market Highlights


Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.


August 20, 2024

  • India Daybook – Stocks in News
  • Sequent Scientific: Company gets prequalification approval from WHO for Albendazole API (Positive)
  • Allcargo logistics: International supply chain monthly operational volume for the month of July stood at 818’000 cubic meters similar to its highest ever monthly volume which was recorded in AUG 2022 (Positive)
  • Zodiac Energy: Net profit at Rs 2.33 cr vs Rs 0.82 cr, Revenue at Rs. 79.59 cr vs Rs 32.54 cr (YoY) (Positive)
  • Quess Corp: Company gets BSE & NSE approval for demerger process. (Positive)
  • Hazoor Multi Projects: Company emerges as lowest bidder for Maharashtra State Infra Development Corp project worth Rs 274 crore (Positive)
  • Nucleus software: Board of Directors meeting is scheduled to be held o… UBS on Cable & Wire Cos
  • Expect:
  • 1) current $8bn segment to be worth $20bn in FY30E & market share of top 5 cos to rise
  • 2) Export revenue to rise from $2bn in FY24 to US$5bn in FY30E, or a 17% CAGR
  • 3) Rev/EBITDA CAGRs to rise 20%/25% in FY24-28E
  • Best play on electrification
  • Initiate Buy on KEI Ind, TP Rs 6150
  • Initiate Buy on Polycab, TP Rs
  • Segment poised to grow at 2x GDP growth in FY24-FY30E
  • UBS On KEI Ind
  • Initiate Buy Call, Target Rs 6,150
  • Co Only Pure Play On Cable & Wires & Consistent Earnings Compounder
  • KEI Offers Multiple Triggers Including Growth For C&W To Sustain For A Longer Period
  • Co Has Scope For Market Share Gains In Branded Housing Wires And Cables
  • Co Has Optionality To Enter Adjacent Electrical Segment (Switches & Switchgears)
  • Co Increased Capex In FY24 To Rs 400 Cr (4x The FY18-23 Average)
  • Expect Capex To Be `700 Cr Annually In FY25-27
  • Capex To Drive Topline And EBITDA CAGRs Of 22% And 31%, Respectively
  • UBS on Polycab
  • Initiate Buy Call, Target Rs 8,550
  • Co Is Cyclical Growth Champion; Beneficiary Long-term Electrification Growth
  • Growth-levered Business Model, Highest Investment Among Peers
  • Significant Room To Grow TAM Revenue Share; FMEG Consumer Pull Is Key
  • Better-than-expected Domestic Volume Growth Is Key Near-term Trigger
  • Domestic Market Share Gains & An Export Ramp-up Are Key Near-term Triggers
  • Citi on M&M
  • Buy Call, Target Cut To Rs 3,180 From Rs 3,340
  • A Tougher Terrain Ahead For SUVs; Tractors Treading Well
  • If FY24 Was ‘Yr Of SUVs For Co, FY25 Is Expected To See Better Momentum In Tractor Segment
  • SUV Demand For Co Has Moderated Vs Earlier Expectations Even As Co Has Expanded Capacity
  • Cut Volume Estimates For Co’s SUV Segment, Resulting In Slight Cuts In Earnings Estimates
  • View On Tractors Remains Positive
  • YTD Volume Growth Is 6% (Including Exports)
  • In The Domestic Market, Co Has Gained Market Share
  • Citi on BPCL
  • Buy Call, Target Rs 380
  • 3 OMCs Have Outperformed Broader Markets YTD By 17-37%
  • Most Of The Outperformance Was Concentrated At Start Of 2024
  • Last 6 Months Underperformance At -9% To -21%
  • Underperformance Reasons Have Been Myriad
  • Underperformance Is Due To Soft GRMs, Weak Marketting Margin Post Fuel Price Cut
  • Believe All These Factors Resulting To Underperformance Till Now Are Now Reversing
  • Nomura on IndusInd Bank
  • Neutral Call, Target Rs 1,580
  • Co Receives RBI Approval To Set Up AMC Subsidiary
  • Co Can Now Generate Revenue As A ‘Manufacturer’ Of Mutual Funds
  • Scale Co Can Attain Will Be Key To Watch
  • MS on HCLTech
  • Overweight Call, Target Rs 1,705
  • Co Appoints Shiv Walia As New CFO Of The Co
  • Shiv Walia Has Been With Co Since Apr’98 & Has Over 3 Decades Of Experience
  • Co Has Generally Seen Relatively Low Attrition At Senior Management Level In Past
  • Departure Of Current CFO Comes As A Negative Surprise Considering Long & Successful Tenure At Co
  • Think Such An Internal Appointment Should Help Make Transition Smooth
  • Such An Internal Appointment Shouldn’t Become An Area Of Concern For Investors
  • Macquarie on TCS
  • O-P, TP raised to Rs 5740
  • Adding to Marquee idea list
  • R&D investments 1-1.2% of rev, but now over $300m/yr
  • Around 600-700 patents filed annually, 3.9K+ patents granted (cumulative)
  • See potential for pickup in demand from a wave of legacy modernisation programs
  • MS on Titagarh Rail
  • Overweight Call, Target Rs 1,337
  • Indian Railways Plans To Procure 90,000 Wagons By CY25
  • Co’s Capacity Enhancement (Freight + Passenger) Would Help Leverage Opportunities
  • Focus On Backward Integration: Forged Wheels And Sub-Components For Coaches
  • Adding Capabilities On Propulsion Manufacturing, To Target Exports As Well
  • Nifty closed @24,572.65 (+31.50) and Sensex @80,424.68 (-12.16) on Monday GIFT Nifty was trading at 24,653 (as of 7:30 am)
  • FIIs net sold equities in cash to the tune of Rs 2667 cr whereas DIIs net bought Rs 1803 cr on August 19 2024
  • SP Group builds a house for $6 bn realty assets plant to take new holding company public in two years
  • ADAG Group moves NCLT to restrain IIHL from using ' brand name
  • Cognizant case US wants L&T chief, 4 other to depose
  • RBI paper sees 54% growth in private capex in FY25
  • Antfin Singapore to sell 408 million stake in Zomato
  • Aurobindo Pharma to commercialise China plant in third quarter of FY 25
  • Audit firm BSR slapped with a Rs 10 cr fine by audit regulator, NFRA, for lapses in audit of Coffee Day Enterprises
  • ONGC Videsh secures contract extension for Vietnam oil blocks
  • Piramal Enterprises promoter group increases stake from the open market to 46.3%
  • LIC has decreased its shareholding in the State owned Hindustan Copper from 8.171% to 6.086%
  • Gold demand rises in India after duty cut, while diamond sales slow
  • Glenmark Pharma hits record high after launch of eye allergy drug in US
  • BEML Gains After Government approves two major metro projects
  • The Murugappa Group has reported a 15.2% jump in its PAT for the year ending March 31 2024 at Rs.7,885 crore
  • Indian ADRs: Wipro (+1.5%), Dr Reddy’s (+1.2%) and Infosys (+1.1%)
Panchkarma